Arcutis Biotherapeutics, Inc. SEC filings ARQT

Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcutis Biotherapeutics, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Nov 4, 2026 —
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 28, 2026 Oct 23, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change
Aug 5, 2026 Jul 31, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
8-K Current report
Shareholder vote results, Other events
Jun 9, 2026 Jun 5, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report May 6, 2026 May 6, 2026
S-8 Employee stock plan registration Apr 21, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Apr 21, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Apr 21, 2026
S-8 Employee stock plan registration Feb 25, 2026 —
S-3ASR Automatic shelf registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 8, 2025 Dec 3, 2025
UPLOAD Letter from the SEC Dec 2, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
CORRESP Letter to the SEC Oct 10, 2025 —
UPLOAD Letter from the SEC Sep 15, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results, Other events
Jun 17, 2025 Jun 12, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 29, 2025 Apr 28, 2025
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 12, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 10, 2025 Apr 10, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 12, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q/A Amended quarterly report Jul 24, 2024 Mar 31, 2024
8-K Current report
Shareholder vote results
Jun 18, 2024 Jun 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 26, 2024 Apr 26, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Apr 26, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 10, 2024 Apr 10, 2024
8-K Current report
Other events
Mar 4, 2024 Feb 28, 2024
424B5 Prospectus supplement Mar 1, 2024 —
424B5 Prospectus supplement Feb 28, 2024 —
8-K Current report
Material agreement
Feb 28, 2024 Feb 27, 2024
S-8 Employee stock plan registration Feb 27, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Officer or director change
Feb 15, 2024 Feb 12, 2024
SC TO-I/A Filing Feb 15, 2024 —
EFFECT Filing Feb 8, 2024 —
424B5 Prospectus supplement Feb 8, 2024 —
CORRESP Letter to the SEC Feb 6, 2024 —
UPLOAD Letter from the SEC Feb 5, 2024 —
S-3 Shelf registration Jan 31, 2024 —
CORRESP Letter to the SEC Jan 24, 2024 —
SC TO-I/A Filing Jan 24, 2024 —
UPLOAD Letter from the SEC Jan 23, 2024 —
SC TO-I Filing Jan 16, 2024 —
SC TO-C Filing Jan 11, 2024 —
8-K Current report
Other events
Jan 11, 2024 Jan 11, 2024
8-K Current report
Other events
Dec 18, 2023 Dec 15, 2023
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 3, 2023 Nov 3, 2023
8-K Current report
Other events
Oct 23, 2023 Oct 19, 2023
424B5 Prospectus supplement Oct 23, 2023 —
424B5 Prospectus supplement Oct 19, 2023 —
8-K Current report
Results of operations, Other events
Oct 19, 2023 Oct 19, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 27, 2023 Sep 27, 2023
UPLOAD Letter from the SEC Sep 18, 2023 —
10-Q/A Amended quarterly report Sep 15, 2023 Jun 30, 2023
10-Q/A Amended quarterly report Sep 15, 2023 Mar 31, 2023
10-K/A Amended annual report Sep 15, 2023 Dec 31, 2022
CORRESP Letter to the SEC Sep 15, 2023 —
UPLOAD Letter from the SEC Sep 8, 2023 —
8-K/A Amended current report
Officer or director change
Sep 7, 2023 Aug 15, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 18, 2023 Aug 15, 2023
8-K Current report
Material agreement
Aug 14, 2023 Aug 10, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 5, 2023 Jun 2, 2023
8-K Current report
Officer or director change, Other events
May 24, 2023 May 22, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
DEFA14A Additional proxy material Apr 18, 2023 —
DEF 14A Proxy statement Apr 18, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Other events
Dec 16, 2022 Dec 12, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Sep 7, 2022 Sep 7, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 6, 2022 Sep 2, 2022
8-K Current report
Other events
Aug 5, 2022 Aug 2, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
424B5 Prospectus supplement Aug 4, 2022 —
424B5 Prospectus supplement Aug 2, 2022 —
8-K Current report
New debt, Other events
Aug 2, 2022 Jul 29, 2022
8-K Current report
Other events
Jun 9, 2022 Jun 6, 2022
8-K Current report
Shareholder vote results
Jun 2, 2022 Jun 1, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 19, 2022 —
DEF 14A Proxy statement Apr 19, 2022 Jun 1, 2022
10-K/A Amended annual report Mar 3, 2022 Dec 31, 2021
S-8 Employee stock plan registration Feb 22, 2022 —
10-K Annual report Feb 22, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 22, 2022 Feb 22, 2022
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Dec 23, 2021 Dec 22, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Other events
Oct 4, 2021 Oct 4, 2021
8-K Current report
Material agreement
Sep 28, 2021 Sep 22, 2021
8-K Current report
Officer or director change
Sep 7, 2021 Sep 3, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2021 Jun 8, 2021
424B5 Prospectus supplement May 6, 2021 —
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
UPLOAD Letter from the SEC May 4, 2021 —
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 9, 2021
CORRESP Letter to the SEC Apr 23, 2021 —
UPLOAD Letter from the SEC Apr 13, 2021 —
8-K Current report
Officer or director change
Mar 26, 2021 Mar 22, 2021
S-8 Employee stock plan registration Feb 16, 2021 —
10-K Annual report Feb 16, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 16, 2021 Feb 16, 2021
8-K Current report
Results of operations, Other events
Feb 5, 2021 Feb 1, 2021
424B5 Prospectus supplement Feb 4, 2021 —
424B5 Prospectus supplement Feb 1, 2021 —
S-3ASR Automatic shelf registration Feb 1, 2021 —
8-K Current report
Other events
Feb 1, 2021 Feb 1, 2021
8-K Current report
Material agreement
Jan 15, 2021 Nov 24, 2020
8-K Current report
Other events
Nov 23, 2020 Nov 23, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change, Other events
Nov 4, 2020 Oct 29, 2020
8-K Current report
Material agreement, Unregistered share sale
Oct 6, 2020 Oct 1, 2020
424B4 Prospectus Oct 5, 2020 —
EFFECT Filing Oct 1, 2020 —
CORRESP Letter to the SEC Sep 29, 2020 —
CORRESP Letter to the SEC Sep 29, 2020 —
S-1 Registration statement Sep 29, 2020 —
8-K Current report
Other events
Sep 29, 2020 Sep 29, 2020
8-K Current report
Other events
Sep 18, 2020 Sep 16, 2020
8-K Current report
Other events
Sep 9, 2020 Sep 8, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
8-K Current report Aug 11, 2020 Aug 11, 2020
8-K Current report
Other events
Jul 31, 2020 Jul 31, 2020
8-K Current report
Officer or director change
Jul 29, 2020 Jul 23, 2020
UPLOAD Letter from the SEC Jul 27, 2020 —
DRS Filing Jul 21, 2020 —
8-K Current report
Results of operations
May 13, 2020 May 12, 2020
10-Q Quarterly report May 12, 2020 Mar 31, 2020
8-K Current report
Material agreement
Apr 29, 2020 Apr 22, 2020
8-K Current report
Officer or director change, Other events
Apr 27, 2020 Apr 23, 2020
10-K Annual report Mar 19, 2020 Dec 31, 2019
424B4 Prospectus Jan 31, 2020 —
S-8 Employee stock plan registration Jan 31, 2020 —
EFFECT Filing Jan 30, 2020 —
S-1MEF Filing Jan 30, 2020 —
SEC STAFF LETTER Filing Jan 29, 2020 —
CERT Filing Jan 29, 2020 —
CORRESP Letter to the SEC Jan 28, 2020 —
CORRESP Letter to the SEC Jan 28, 2020 —
SEC STAFF LETTER Filing Jan 27, 2020 —
8-A12B Filing Jan 21, 2020 —
S-1/A Amended registration statement Jan 21, 2020 —
CORRESP Letter to the SEC Jan 13, 2020 —
S-1 Registration statement Jan 6, 2020 —
DRS/A Filing Dec 13, 2019 —
DRSLTR Filing Nov 12, 2019 —
DRS/A Filing Nov 12, 2019 —
UPLOAD Letter from the SEC Oct 31, 2019 —
D Filing Oct 22, 2019 —
DRS/A Filing Oct 21, 2019 —
DRSLTR Filing Oct 18, 2019 —
UPLOAD Letter from the SEC Oct 7, 2019 —
DRS Filing Sep 9, 2019 —

Showing 191 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARQT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westlake Village, CA
SEC filer status
Large accelerated filer
SEC CIK
1787306
Former names
Arcutis, Inc. (until Sep 9, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.